Antitumor effect of interleukin-2 against renal cell carcinoma

M. Oya, K. Marumo, H. Tazaki

Research output: Contribution to journalArticlepeer-review


Renal cell carcinoma (RCC) is one of the most insensitive urologic tumors to either radiotherapy or anticancer chemotherapy. Several reports have shown that interferon (IFN) is the agent of great promise to treat advanced RCC. However, the effectiveness of IFN is limited.1) Eighteen patients with advanced RCC were treated by IL2. Antitumor effects were evaluated according to immunological parameters and survival rates.

Original languageEnglish
Pages (from-to)129-130
Number of pages2
JournalAnnals of Cancer Research and Therapy
Issue number1
Publication statusPublished - 1993


  • Interleukin-2
  • Renal cell carcinoma

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Pharmacology (medical)


Dive into the research topics of 'Antitumor effect of interleukin-2 against renal cell carcinoma'. Together they form a unique fingerprint.

Cite this